Levodopa, manganese, and degenerations of the brain.
D000284:Administration, Oral; D000818:Animals; D001058:Apomorphine / Q000008:administration & dosage / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D001927:Brain Diseases / Q000188:drug therapy*; D002250:Carbon Radioisotopes; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D004044:Dietary Proteins; D004298:Dopamine / Q000378:metabolism; D004359:Drug Therapy, Combination; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007267:Injections; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020149:Manganese Poisoning; D009069:Movement Disorders / Q000209:etiology; D009501:Neutron Activation Analysis; D010300:Parkinson Disease / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011868:Radioisotopes
D002250:Carbon Radioisotopes; D004044:Dietary Proteins; D011868:Radioisotopes; D007980:Levodopa; D013006:Growth Hormone; D001058:Apomorphine; D004298:Dopamine